acs kuliah magister(1)

Upload: rabiahirfah

Post on 01-Jun-2018

222 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/9/2019 Acs Kuliah Magister(1)

    1/66

    CUTE CORON RY

    SYNDROME

    PROGRAM PENDIDIKAN MAGISTER

    KEDOKTERAN JANTUNG DAN PEMBULUH DARAH

    FAKULTAS KEDOKTERAN

    UNIVERSITAS SUMATERA UTARA

    PRESENTATOR : dr.MARWAN NASRI

    PEMBIMBING : Prof.dr.HARRIS HASAN,SP.PD (K), SP.JP (K)

  • 8/9/2019 Acs Kuliah Magister(1)

    2/66

    DEFINITION

    Acute coronary syndrome (ACS) refers to a

    spectrum of clinical presentations ranging from

    those for ST-segment elevation myocardial

    infarction (STEMI) to presentations found in

    nonST segment elevation myocardial infarction

    (STEMI) or in unsta!le angina"

    It is almost al#ays associated #ith rupture of anatherosclerotic pla$ue and partial or complete

    throm!osis of the infarct-related artery"

  • 8/9/2019 Acs Kuliah Magister(1)

    3/66

    UNIVERSAL DEFENITION

    MYOCARDIAL INFARCTION

  • 8/9/2019 Acs Kuliah Magister(1)

    4/66

    UNIVERSAL DEFINITION OF

    MYOCARDIAL INFARCTION

  • 8/9/2019 Acs Kuliah Magister(1)

    5/66

    5

    Hospitalizations in the U.S. Due to

    Acute Coronary Syndromes (ACS)

    Acute CoronarySyndromes*

    1.57 Million Hospital Admissions - ACS

    UA/NSTM!% STM!

    1."# millionAdmissions per year

    .$$ millionAdmissions per year

    Heart %isease and Stro&e Statistics ' "((7 Update. Circulation

    "((7) 115+,-171. *rimary and secondary dianoses. A0out(.57 million NSTM! and (.+7 million UA.

  • 8/9/2019 Acs Kuliah Magister(1)

    6/66

  • 8/9/2019 Acs Kuliah Magister(1)

    7/66

    ATHEROSCLEROSISTIMELINE

  • 8/9/2019 Acs Kuliah Magister(1)

    8/66

    MECHANISMS OF

    CORONARY THROMBOSIS

    Lilly. Pathophysiology of Heart Disease, 4th Ed. Lippincott Williams, 2007. Page 7

  • 8/9/2019 Acs Kuliah Magister(1)

    9/66

    CONSEQUENCES OF

    CORONARY THROMBOSIS

    Lilly. Pathophysiology of Heart Disease, 4th Ed. Lippincott Williams, 2007. Page 7!

  • 8/9/2019 Acs Kuliah Magister(1)

    10/66

    INITI L

    EV LU TION

    ND

    M N GEMEN

    T

  • 8/9/2019 Acs Kuliah Magister(1)

    11/66

  • 8/9/2019 Acs Kuliah Magister(1)

    12/66

    CHEST PAIN

  • 8/9/2019 Acs Kuliah Magister(1)

    13/66

    ECG ASSESSMENT

  • 8/9/2019 Acs Kuliah Magister(1)

    14/66

    ECG ASSESSMENT

    ECG manifestations of acute myocardial

    ischaemia in a!sence of L"H and L###$

    ECG chan%es associated &ith 'rior

    myocardial infarction

    AC(TE STEMI

  • 8/9/2019 Acs Kuliah Magister(1)

    15/66

    Lilly. Pathophysiology of Heart Disease, 4th Ed. Lippincott Williams, 2007. Page "2

    AC(TE STEMIE"OL(TION

  • 8/9/2019 Acs Kuliah Magister(1)

    16/66

    BIOM RKER FOR CS

  • 8/9/2019 Acs Kuliah Magister(1)

    17/66

  • 8/9/2019 Acs Kuliah Magister(1)

    18/66Copyrit 2"((7 American Collee o3 Cardioloy 4oundation. estrictions may apply.

    Anderson) *+ L+ et al+ * Am Coll Cardiol ,--./0-1e23e20.

    TIMING OF RELE SE OF V RIOUS BIOM RKERS

    FTER CUTE MYOC RDI L INF RCTION

  • 8/9/2019 Acs Kuliah Magister(1)

    19/66

    BIOM RKER FOR CS

    E#ropean Heart $o#rnal %20& !2,2''' ( !0)4

  • 8/9/2019 Acs Kuliah Magister(1)

    20/66

    TROPONIN KINETICS IN THE INDEX C SES

    6aha3an 78 +arolim #. Circulation 20,2/:290129/

    *opyright + merican Heart ssociation, -nc. ll rights resered.

  • 8/9/2019 Acs Kuliah Magister(1)

    21/66

  • 8/9/2019 Acs Kuliah Magister(1)

    22/66

    /reatment of c#te/reatment of c#te

    *oronary yndromes1*oronary yndromes1

    /E s. on /E/E s. on /E

  • 8/9/2019 Acs Kuliah Magister(1)

    23/66

    &reatment o% Acute Coronary&reatment o% Acute CoronarySyndromesSyndromes

    Anti1ischemic therapiesAnti1ischemic therapies

    eneral measures:eneral measures:

    Antithrom;otic therapiesAntithrom;otic therapiesAntiplatelet aents:Antiplatelet aents:

    Anticoaulants (use one):Anticoaulants (use one):

    Ad3uncti'e therapies:Ad3uncti'e therapies:

    33(loc5er(loc5er itratesitrates 6( *alci#m channel loc5er6( *alci#m channel loc5er

    Pain control %morphine&Pain control %morphine& #pplemental 8#pplemental 822if neededif needed

    spirinspirin *lopidogrel %or pras#grel&*lopidogrel %or pras#grel& 9P -----a inhiitor %for selected high9P -----a inhiitor %for selected high

    ris5 patients: may e deferred #ntil P*-&ris5 patients: may e deferred #ntil P*-&

    L;WH %eno

  • 8/9/2019 Acs Kuliah Magister(1)

    24/66

  • 8/9/2019 Acs Kuliah Magister(1)

    25/66

  • 8/9/2019 Acs Kuliah Magister(1)

    26/66

    STEMI

  • 8/9/2019 Acs Kuliah Magister(1)

    27/66

    REPERFUSI

  • 8/9/2019 Acs Kuliah Magister(1)

    28/66

  • 8/9/2019 Acs Kuliah Magister(1)

    29/66

    R!"#$$!%&'()#% *#+ R!,!+*-.)#% T/!+',

  • 8/9/2019 Acs Kuliah Magister(1)

    30/66

    REPERFUSION THERAPY FOR STEMI

  • 8/9/2019 Acs Kuliah Magister(1)

    31/66

    Date of doAnload1422204

    *opyright + /he merican *ollege of *ardiology.ll rights resered.

    From: eper%usion Strateies in Acute S&1Sement !le'ation 6yocardial $n%arction: A Comprehensi'e e'ie